As of Apr 24
| +0.31 / +6.34%|
The 3 analysts offering 12-month price forecasts for Anthera Pharmaceuticals Inc have a median target of 7.50, with a high estimate of 12.00 and a low estimate of 1.00. The median estimate represents a +44.23% increase from the last price of 5.20.
The current consensus among 3 polled investment analysts is to Buy stock in Anthera Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.